In 2019, the transaction volumes of private non-oncology biopharma companies reached 12.2 billion U.S. dollars, whereas the values for oncology companies were at 4.1 billion U.S. dollars. This statistic shows the M&A transaction volumes of private venture capital-backed oncology vs. non-oncology biopharma companies in U.S. and Europe from 2010 to 2019.
M&A transaction volumes of private U.S. and European VC-backed oncology vs. non-oncology biopharma companies from 2010 to 2019
(in billion U.S. dollars)
Total transaction values (including contingent payments) of completed trade sales of private VC-backed U.S. and European biopharma companies (all transaction sizes).
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
HBM Partners. (February 1, 2020). M&A transaction volumes of private U.S. and European VC-backed oncology vs. non-oncology biopharma companies from 2010 to 2019 (in billion U.S. dollars) [Graph]. In Statista. Retrieved December 22, 2024, from https://www.statista.com/statistics/1093697/vc-biopharma-company-trade-sales-transaction-volumes-oncology-us-europe/
HBM Partners. "M&A transaction volumes of private U.S. and European VC-backed oncology vs. non-oncology biopharma companies from 2010 to 2019 (in billion U.S. dollars)." Chart. February 1, 2020. Statista. Accessed December 22, 2024. https://www.statista.com/statistics/1093697/vc-biopharma-company-trade-sales-transaction-volumes-oncology-us-europe/
HBM Partners. (2020). M&A transaction volumes of private U.S. and European VC-backed oncology vs. non-oncology biopharma companies from 2010 to 2019 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: December 22, 2024. https://www.statista.com/statistics/1093697/vc-biopharma-company-trade-sales-transaction-volumes-oncology-us-europe/
HBM Partners. "M&a Transaction Volumes of Private U.S. and European Vc-backed Oncology Vs. Non-oncology Biopharma Companies from 2010 to 2019 (in Billion U.S. Dollars)." Statista, Statista Inc., 1 Feb 2020, https://www.statista.com/statistics/1093697/vc-biopharma-company-trade-sales-transaction-volumes-oncology-us-europe/
HBM Partners, M&A transaction volumes of private U.S. and European VC-backed oncology vs. non-oncology biopharma companies from 2010 to 2019 (in billion U.S. dollars) Statista, https://www.statista.com/statistics/1093697/vc-biopharma-company-trade-sales-transaction-volumes-oncology-us-europe/ (last visited December 22, 2024)
M&A transaction volumes of private U.S. and European VC-backed oncology vs. non-oncology biopharma companies from 2010 to 2019 (in billion U.S. dollars) [Graph], HBM Partners, February 1, 2020. [Online]. Available: https://www.statista.com/statistics/1093697/vc-biopharma-company-trade-sales-transaction-volumes-oncology-us-europe/
